Agreement

Nevada Lithium provides positive update on Hydraulic Borehole Mining method and commences updated Preliminary Economic Assessment for Bonnie Claire Lithium Project, Nevada

Retrieved on: 
Tuesday, April 16, 2024
Lithium, Well, USD, PFS, Project, Agreement, PEA, Atmosphere of Earth, Production, Aircraft pilot, News, Technical report, GRE, Blue, Cave, Jet, Oil, CAPEX, Toronto Stock Exchange, Metallurgy, Tax, Technische Universität Darmstadt, Bonnie, Vacuum, CAD, Generation, OPEX, Great Basin

The Company is also pleased to announce the commencement of an updated Preliminary Economic Assessment (“PEA”) on the Project.

Key Points: 
  • The Company is also pleased to announce the commencement of an updated Preliminary Economic Assessment (“PEA”) on the Project.
  • Nevada Lithium’s CEO, Stephen Rentschler, commented: “Nevada Lithium has received an updated assessment of the Hydraulic Borehole Mining (HBHM) method from an internationally recognized leader in the HBHM mining technique, Kinley Exploration LLC.
  • While this method has been used elsewhere, Bonnie Claire would see its use in the Great Basin for the first time.
  • The objective of this work is to establish a reasonable economic mining strategy to extract lithium in a continuous, cost effective and safe manner.

Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™

Retrieved on: 
Tuesday, April 16, 2024
FDA, Agreement, Society, OTCQB, Food, De novo, Flushing, CABG, Patient, Pharmaceutical industry

JUPITER, FL, April 16, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Marizyme, Inc. ("Marizyme", OTCQB: MRZM) announces today a Co-Development Agreement (the “Agreement”) with Qualigen Therapeutics, Inc. (“Qualigen”) (NASDAQ: QLGN ) to advance the commercialization of Marizyme’s first-in-class FDA cleared product, DuraGraft™.

Key Points: 
  • JUPITER, FL, April 16, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Marizyme, Inc. ("Marizyme", OTCQB: MRZM) announces today a Co-Development Agreement (the “Agreement”) with Qualigen Therapeutics, Inc. (“Qualigen”) (NASDAQ: QLGN ) to advance the commercialization of Marizyme’s first-in-class FDA cleared product, DuraGraft™.
  • DuraGraft™ was granted a De Novo – FDA Clearance on October 4, 2023, from the U.S. Food and Drug Administration (FDA).
  • David Barthel, CEO of Marizyme, stated: “This is an exciting opportunity for Marizyme to accelerate the commercialization of DuraGraft™.
  • This agreement provides Qualigen with participation in an FDA-cleared commercialization project with a visible path to revenue generation in the short term.

ThreeD Capital Inc. Announces Securities Purchase Agreement with Lophos Holdings Inc.

Retrieved on: 
Monday, April 15, 2024
Agreement, Partnership, EarthBound, Research, IDK, Investment, Security (finance)

TORONTO, April 15, 2024 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce that the Company has entered into a proposed Securities Purchase Agreement (the “Agreement”) with Lophos Holdings Inc. (“Lophos”).

Key Points: 
  • TORONTO, April 15, 2024 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce that the Company has entered into a proposed Securities Purchase Agreement (the “Agreement”) with Lophos Holdings Inc. (“Lophos”).
  • Under the terms of the Agreement, Lophos will issue and sell 2,125,000 common shares (the "Purchased Lophos Shares") and 2,125,000 common share purchase warrants (the "Purchased Lophos Warrants", collectively the "Purchased Lophos Units") to ThreeD at a price of $0.06 per Purchased Lophos Unit.
  • Each Purchased Lophos Warrant will entitle the holder to purchase one common share of Lophos at $0.10 until three years from the Closing Time.
  • "We are delighted to unveil our strategic partnership with ThreeD Capital Inc., a pivotal moment for Lophos Holdings Inc. as we further our footprint in the bioscience and wellness sectors.

AXIL Signs Agreement with Beretta Hellas LTD to Distribute AXIL Hearing Protection and Enhancement Products in Greece

Retrieved on: 
Monday, April 15, 2024
Agreement, GS, Partnership

LOS ANGELES, April 15, 2024 (GLOBE NEWSWIRE) -- AXIL Brands, Inc. (“AXIL,” “we,” “us,” “our,” or the “Company”) (NYSE American: AXIL), an emerging global consumer products company for AXIL® hearing protection and enhancement products and Reviv3® hair and skin care products, today announced a distribution agreement (“Agreement”) with Beretta Hellas LTD, a subsidiary of Beretta Holdings to distribute AXIL hearing protection products in Greece.

Key Points: 
  • LOS ANGELES, April 15, 2024 (GLOBE NEWSWIRE) -- AXIL Brands, Inc. (“AXIL,” “we,” “us,” “our,” or the “Company”) (NYSE American: AXIL), an emerging global consumer products company for AXIL® hearing protection and enhancement products and Reviv3® hair and skin care products, today announced a distribution agreement (“Agreement”) with Beretta Hellas LTD, a subsidiary of Beretta Holdings to distribute AXIL hearing protection products in Greece.
  • The Agreement presents a unique opportunity for AXIL to expand its EU presence in partnership with a highly prestigious brand and a staple within the hunting, sporting, and defense community.
  • The Agreement includes AXIL’s lineup of hearing performance systems, including GS Extreme 2.0®, XCOR®, XCOR Digital®, and the Trackr™ series hearing solutions.
  • Beretta Hellas has a presence in all the important shooting ranges in Greece and sponsors major events and competitions, having a stable presence in shooting ranges and an ascending progress in the field.

ThreeD Capital Inc. Announces Agreement with Passive Income Investor Inc.

Retrieved on: 
Friday, April 12, 2024
Agreement, IDK, EarthBound, Social media, News

TORONTO, April 12, 2024 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce that it has entered into a new agreement (the “Agreement”) with Passive Income Investor Inc. (“Passive Income Investor”) to provide investor relations services to the Company.

Key Points: 
  • TORONTO, April 12, 2024 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce that it has entered into a new agreement (the “Agreement”) with Passive Income Investor Inc. (“Passive Income Investor”) to provide investor relations services to the Company.
  • Passive Income Investor is entirely arm's length to ThreeD.
  • The services provided by Passive Income Investor are to commence on April 12, 2024 and will continue for a three-month term.
  • Passive Income Investor will engage with investors through various digital marketing and social media platforms, to facilitate greater investor awareness and widespread dissemination of ThreeD Capital’s news.

Contango Announces Acquisition of HighGold

Retrieved on: 
Thursday, May 2, 2024
Natural Resources, Other Natural Resources, Mining, Minerals, LLP, Risk, Par value, Blake, Cassels & Graydon, Contango, Partnership, Transaction, EST, Holland & Knight, Meeting, News, Gold, VWAP, Agreement, CIRI, Native, Alaska Native corporation, National instrument, PST, Organization, OTCQX, DSO, Senior, 100.9 ZZZ FM, Regulation, Growth

Under the terms of the Agreement, each HighGold share (“HighGold Share”) will be exchanged for 0.019 shares of Contango common stock (each whole share, a “Contango Share”) (the “Exchange Ratio”) based on the respective volume weighted average price (“VWAP”) of Contango for the five-day period ending on May 1, 2024.

Key Points: 
  • Under the terms of the Agreement, each HighGold share (“HighGold Share”) will be exchanged for 0.019 shares of Contango common stock (each whole share, a “Contango Share”) (the “Exchange Ratio”) based on the respective volume weighted average price (“VWAP”) of Contango for the five-day period ending on May 1, 2024.
  • Upon completion of the Transaction, existing Contango shareholders will own approximately 85% and HighGold shareholders will own approximately 15% of the combined company3.
  • In connection with the Transaction, Contango will grant to HighGold the right to appoint one (1) director to its board of directors.
  • Participants may join the webcast using the following call-in details: Contango ORE Announces Acquisition of HighGold (6ix.com)
    Creation of a leading Alaskan gold company with a low-risk and properly sequenced portfolio – Manh Choh is Alaska’s next gold mine with first gold pour expected in the second half of 2024.

Ether Capital Announces Conclusion of its Strategic Review and Enters into an Agreement with Purpose Unlimited to Convert into a Staking Ether ETF

Retrieved on: 
Thursday, May 2, 2024
Professional Services, Technology, Blockchain, Other Technology, Finance, Fintech, Bitcoin, Agreement, Meeting, LLP, Ecosystem, ETF, Investment, Interim management, NAV, Framework, TSX, Multilateral, ETHC, Indian stock exchange, BTCC, Ontario Securities Commission, AUM, Transaction, Fund, Market, Interim, Minority, Asset management

Ether Capital Corporation (Cboe CA: ETHC) today announces the results of its strategic review.

Key Points: 
  • Ether Capital Corporation (Cboe CA: ETHC) today announces the results of its strategic review.
  • The Corporation would retain its Ether, cash and cash equivalents, which would become portfolio assets of the Fund.
  • The Corporation holds approximately 46,317 Ether, approximately 98% of which is staked, with the majority on its proprietary internally managed infrastructure.
  • It is worth noting that Purpose was a core partner in the founding and development of Ether Capital in 2018.

Mogo Congratulates WonderFi and KAOS Capital on Cooperation Agreement and Expresses Support for Shareholder-Friendly Decision to Nominate Three New Directors

Retrieved on: 
Wednesday, May 1, 2024
Finance, Cryptocurrency, Payments, Professional Services, Technology, Agreement, Issuer, TSX, Amendment, Acquisition, National instrument, KAOS, Inc., Bank statement, Growth, IRA, AGM

The Company also expressed its support for the cooperation agreement between WonderFi and KAOS Capital Ltd. (“KAOS”) (the “Agreement”).

Key Points: 
  • The Company also expressed its support for the cooperation agreement between WonderFi and KAOS Capital Ltd. (“KAOS”) (the “Agreement”).
  • Mogo has also agreed to sell up to 20 million of its approximately 87 million WonderFi shares over time and subject to certain terms and conditions.
  • In connection with the entering into of the Agreement, KAOS and Mogo also agreed to terminate the Voting Agreement.
  • Mogo’s ownership and control of WonderFi shares remained unchanged following the execution of the Amendment and termination of the Voting Agreement.

Zuora Appoints John D. Harkey, Jr. to Board of Directors

Retrieved on: 
Wednesday, May 1, 2024
Software, Technology, Professional Services, Business, Agreement, University, Investment, LP, Audit committee, Principal, Therapy, Novartis, Moses Austin, Novartis Gene Therapies, Management

Zuora, Inc. (NYSE: ZUO), a leading monetization suite for modern business, today announced the appointment of John D. Harkey, Jr. to the Zuora Board of Directors, effective April 30, 2024.

Key Points: 
  • Zuora, Inc. (NYSE: ZUO), a leading monetization suite for modern business, today announced the appointment of John D. Harkey, Jr. to the Zuora Board of Directors, effective April 30, 2024.
  • With the addition of Mr. Harkey, the Zuora Board of Directors will consist of ten Board members, nine of whom are independent.
  • Over the course of his career, Mr. Harkey has previously served on the board of directors of nine public companies.
  • Mr. Harkey currently serves on the Board of Directors and Audit Committee of Lionsgate Entertainment Corp., is the Chairman of the Board of Directors of Dialectic Therapeutics, Inc., and Chairman of the Board of Veterinary Service, Inc. Mr. Harkey received his B.B.A.

Walgreens Boots Alliance Provides Summary Notice of Pending and Proposed Settlement of Shareholder Derivative Action

Retrieved on: 
Wednesday, May 1, 2024
Class Action Lawsuit, Professional Services, Legal, Agreement, Hearing, Security (finance), COMMON, READ, District court, ALL, Judgement, Action

TO: ALL PERSONS WHO OWNED SHARES OF THE COMMON STOCK OF WALGREENS BOOTS ALLIANCE, INC. (“WALGREENS” OR THE “COMPANY”) AS OF APRIL 10, 2024 (“WALGREENS SHAREHOLDERS”).

Key Points: 
  • TO: ALL PERSONS WHO OWNED SHARES OF THE COMMON STOCK OF WALGREENS BOOTS ALLIANCE, INC. (“WALGREENS” OR THE “COMPANY”) AS OF APRIL 10, 2024 (“WALGREENS SHAREHOLDERS”).
  • A more detailed Notice of Pendency and Proposed Settlement of Shareholder Derivative Action and of Settlement Hearing (the “Notice”) that provides additional information concerning the Action, the terms of the proposed Settlement, and Walgreens Shareholders’ legal rights with respect to the proposed Settlement is being furnished to the Securities and Exchange Commission.
  • PLEASE DO NOT CONTACT THE COURT, THE CLERK’S OFFICE, OR WALGREENS REGARDING THIS NOTICE OR THE PROPOSED SETTLEMENT.
  • All questions about this notice or the proposed Settlement should be directed to the following counsel for Plaintiff: